Seres Therapeutics - May Offer Up To $300 Million Of Securities
MCRB•Seres Therapeutics filing outlines potential securities offering
Aug. 13 (Reuters) - Seres Therapeutics, Inc. MCRB.O:
- Seres Therapeutics may offer up to $300 million of securities, according to an SEC filing.
- Seres Therapeutics may sell up to $100 million in common stock under a sales agreement, according to the same filing.
Further company coverage: MCRB.O




